MiPod Nuclear is in licensing deal for isotope technology

10/20/2010 | Yahoo!

MiPod Nuclear has entered a licensing deal that gives Vector Trading exclusive rights to its patent-pending technology for the production of Mo-99 medical isotope. The agreement covers the use of the technology, which will employ depleted uranium in its procedure, in Australia and New Zealand.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI